Clinical Trials · NCT02960659
Title: Therapeutic Targets in African-American Youth With Type 2 Diabetes
- Phase
- Phase 1/Phase 2
- Recruitment status
- Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Enrollment
- 24
- Start date
- May 2017
- Locations
- 1 site, United States
- Primary endpoint
- Change in Absolute Gluconeogenesis From Baseline to 12 Weeks